HEREDITARY PORCINE MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE-II IS CAUSED BY FACTOR-H DEFICIENCY

被引:181
作者
HOGASEN, K
JANSEN, JH
MOLLNES, TE
HOVDENES, J
HARBOE, M
机构
[1] NORWEGIAN COLL VET MED,DEPT MORPHOL GENET & AQUAT BIOL,SECT PATHOL,N-0033 OSLO,NORWAY
[2] NORLAND CENT HOSP,DEPT IMMUNOL & TRANSFUS MED,N-8017 BODO,NORWAY
[3] UNIV TROMSO,N-8017 BODO,NORWAY
关键词
GLOMERULONEPHRITIS; MESANGIOCAPILLARY; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATORS; COMPLEMENT PATHWAY; ALTERNATIVE; HEREDITARY DISEASES;
D O I
10.1172/JCI117751
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have recently described hereditary membranoproliferative glomerulonephritis type II in the pig. All affected animals had excessive complement activation, revealed as low plasma C3, elevated plasma terminal complement complex, and massive deposits of complement in the renal glomeruli, and eventually died of renal failure within 11 wk of birth. The aim of the present study was to investigate the cause of complement activation in this disease. Transfusion of normal porcine plasma to affected piglets inhibited complement activation and increased survival. Plasma was successively fractionated and the complement inhibitory effect of each fraction tested in vivo. A single chain 150-kD protein which showed the same complement inhibitory effect as whole plasma was finally isolated. Immunologic cross-reactivity, functional properties, and NH2-terminal sequence identified the protein as factor H. By Western blotting and enzyme immunoassay, membranoproliferative glomerulonephritis-affected piglets were demonstrated to be subtotally deficient in factor H. At 1 wk of age, median (range) factor H concentration was 1.6 mg/liter (1.1-2.3) in deficient animals (n = 13) and 51 mg/liter (26-98) in healthy littermates (n = 52). Our data show that hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.
引用
收藏
页码:1054 / 1061
页数:8
相关论文
共 35 条
  • [1] COMBINED HOMOZYGOUS FACTOR-H AND HETEROZYGOUS C2 DEFICIENCY IN AN ITALIAN FAMILY
    BRAI, M
    MISIANO, G
    MARINGHINI, S
    CUTAJA, I
    HAUPTMANN, G
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1988, 8 (01) : 50 - 56
  • [2] CHARLESWORTH JA, 1979, CLIN EXP IMMUNOL, V38, P397
  • [3] CHOI NH, 1988, CHEM PHARM BULL, V36, P3008
  • [4] DAHA MR, 1976, J IMMUNOL, V116, P1
  • [5] HUMAN-COMPLEMENT FACTOR-H - 2 FACTOR-H PROTEINS ARE DERIVED FROM ALTERNATIVELY SPLICED TRANSCRIPTS
    ESTALLER, C
    SCHWAEBLE, W
    DIERICH, M
    WEISS, EH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (03) : 799 - 802
  • [6] ESTALLER C, 1991, J IMMUNOL, V146, P3190
  • [7] FIJEN CAP, 1989, LANCET, V2, P585
  • [8] Galfre G, 1981, Methods Enzymol, V73, P3
  • [9] Habib R, 1973, Clin Nephrol, V1, P194
  • [10] HAMMER CH, 1981, J BIOL CHEM, V256, P3995